Why Acadia Pharmaceuticals Inc. Stock Slipped 19% in 2016

Why Acadia Pharmaceuticals Inc. Stock Slipped 19% in 2016

What happened Shares of Acadia Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on treating central nervous system disorders, fell 19.1% last year, according to data from S&P Global Market Intelligence. Clinical trials with its lead drug, Nuplazid, gave mixed signals regarding an important label expansion. So what  Nuplazid recently earned approval from the Food and Drug Administration as → Read More

These 3 Stocks Quadrupled in Just 1 Year

These 3 Stocks Quadrupled in Just 1 Year

Investors love stocks that give them massive returns. The most common way to get huge gains is to invest for the long run, counting on fundamental business success to produce ample dividends and lucrative share-price appreciation. Yet sometimes, gains come in a very quick period of time, and a very small number of stocks have → Read More

5 Uranium Statistics That Will Blow You Away

5 Uranium Statistics That Will Blow You Away

Investors are right to be mindful of uranium's image problems. But the negatives surrounding uranium and nuclear power can offer up long-term buying opportunities, too. Since the 2011 Fukushima disaster in Japan, uranium prices have been in a downtrend, pulling down the prices of miners like Cameco Corp (NYSE:CCJ). But if you are willing to → Read More

Why Arena Pharmaceuticals Stock Sank in 2016

Why Arena Pharmaceuticals Stock Sank in 2016

What happened Like most biotechs, Arena Pharmaceuticals (NASDAQ:ARNA) had a rough 2016. The small-cap biotech's shares fell by a whopping 22.4% last year, according to data from S&P Global Market Intelligence.  Arena's stock suffered from both the poor commercial performance of its prescription obesity medication Belviq that's marketed by Japan's Eisai Co., as well as its → Read More

Taking Out a 401(k) Loan? What You Should Know

Taking Out a 401(k) Loan? What You Should Know

If you needed to borrow cash, where would you go? A bank? A peer-to-peer lending platform? A payday lender? A relative? Miranda, who lives just outside Cleveland, Ohio, chose to go to a different source of funding: a 401(k) account. She and her husband researched borrowing options for nearly a year before deciding to borrow $20,000 → Read More

Why Ford's CEO Thinks Profits Will Dip in 2017

Why Ford's CEO Thinks Profits Will Dip in 2017

Ford Motor Company (NYSE:F) expects its profit to dip a bit in 2017 as it makes some big investments for the future. But it expects its profit to recover — and then some — in 2018 and beyond. That was the key takeaway in Ford's 2017 guidance, as delivered by CEO Mark Fields in a → Read More

Chinese exports fall as Beijing braces for Trump

Chinese exports fall as Beijing braces for Trump

America's complicated, critical trade relations with China Donald Trump has attacked China for using underhanded means to boost its exports at America's expense. But right now, the view from Beijing isn't looking so rosy. Chinese exports fell 2% last year, according to official data released Friday. That's the biggest annual decline since 2009. Read More

When Are Taxes Due in 2017?

When Are Taxes Due in 2017?

Just like last year, the 2017 federal tax return deadline doesn't fall on the usual date of April 15. Federal tax payments and personal income tax filings for the 2016 tax year are due on April 18, 2017. Those who file in two U.S. states, Maine and Massachusetts, score an extra day — their filings → Read More

Why AK Steel Holding Corporation Lost 10% Yesterday

Why AK Steel Holding Corporation Lost 10% Yesterday

What happened Steelmaker AK Steel (NYSE:AKS) closed trading down 10.4% on Thursday, rebounding only slightly after a sell-off that saw the stock down more than 11% at one point. So what Looking for someone to blame? Try Credit Suisse. On Thursday, the Swiss megabanker took an axe to its stock ratings for AK Steel — → Read More

Arconic Inc's Stock Plunged 18% in 2016: Here's Why It's Worth Buying Now

Arconic Inc's Stock Plunged 18% in 2016: Here's Why It's Worth Buying Now

When Arconic Inc (NYSE:ARNC) and Alcoa Corporation (NYSE:AA) split into two separate companies late in 2016, I generally favored Arconic as the better long-term investment. But an interesting and somewhat unexpected thing happened: Alcoa shares rocketed up while the market beat Arconic's stock down pretty soundly: While Arconic has regained some of its stock losses, the market hasn't really → Read More

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.